Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 2 of 4)
This article was originally published in The Pink Sheet Daily
Executive Summary
In part II of a series, panelists discuss venture capital, NIH grants, SBIR and foundation funding, as ways to support discovery.
You may also be interested in...
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 4 of 4)
Can drug companies, government and academia solve the big problems together without cries of conflicted interest?
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 4 of 4)
Can drug companies, government and academia solve the big problems together without cries of conflicted interest?
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 3 of 4)
Panelists discuss asset valuation, the scarcity of viable candidates in some parts of the neuro sector and the need for novel ways of funding early development.